Navigation Links
Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
Date:8/20/2008

Collaboration Will Seek to Identify microRNAs Implicated in HIV Viral

Replication and Their Function Samples Will be Screened and Analyzed Using Rosetta Genomics' Proprietary

microRNA Technologies

REHOVOT, Israel and JERSEY CITY, New Jersey, August 20 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today a collaboration with the National Institute of Health to identify microRNAs involved in the progression of the Human Immunodeficiency Virus (HIV), that may be used as potential drug targets.

Rosetta Genomics has access to the majority of known human and viral microRNAs. From this strong intellectual property position, the company has developed highly sensitive, proprietary technologies to detect and quantify microRNAs. These technologies are based on publicly known human and viral microRNAs in addition to Rosetta Genomics proprietary microRNAs, which are yet to be published. Leveraging Rosetta Genomics' extensive know-how in microRNAs and proprietary technologies, this collaboration will seek to determine the role of microRNAs in HIV viral replication, and their potential to act as novel drug targets for future therapy.

"We are very excited to be collaborating with the NIH in seeking to better understand the link between the aberrant expression of microRNAs and the viral replication of HIV, and to identify potential microRNA drug targets", said Dr. Zvi Bentwich, Chief Scientist of Rosetta Genomics and a world renowned HIV researcher. "Having the opportunity to work with the NIH on this important collaboration is a reflection on our leading capabilities and know how in this field."

In a study published last year (Zhang et al. Nature Medicine, 2007), researchers showed that microRNAs are involved in suppressing HIV replication' and keeping it latent. Through this collaboration, Rosetta Genomics and the NIH aim to deepen the understanding of the role microR
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Rosetta Genomics Reports Second Quarter 2008 Financial Results
2. Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
3. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
4. Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
5. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
6. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
7. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
8. /C O R R E C T I O N -- Rosetta Genomics Ltd/
9. Rosetta Genomics Reports First Quarter 2008 Financial Results
10. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
11. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)...  Spherix Incorporated (Nasdaq: SPEX ) -- an intellectual property ... intellectual property, today announced a litigation update. ... Services Corp. et al. , Case No. 1:14-cv-00721-GBL-TCB, in ... of Virginia , the Court issued ... key claims in favor of the Defendants on the ...
(Date:7/1/2015)... and PARIS , July ... and Genective, key developer of biotech crops, today ... of new generations of insect control traits. ... to counter the realities of advancing insect resistance. ... AgBiome,s unique insect control technology with Genective,s capability ...
(Date:7/1/2015)... 2015  Axovant Sciences Ltd. (NYSE:  AXON), a ... of dementia, today announced that the company will ... 5:45 p.m. EDT following its presentation of RVT-101 ... 2015 (AAIC). The event will ... Lawrence Friedhoff , Chief Development Officer, will ...
(Date:7/1/2015)... ... July 01, 2015 , ... NEMA 4 (IP66) Medical ... new Medical Joysticks have an impermeable molecular barrier protection against bio-hazardous agents. ... that will increase healthcare worker safety and reduce financial costs. , CTI Electronics ...
Breaking Biology Technology:Spherix Issues A Litigation Update 2Spherix Issues A Litigation Update 3AgBiome and Genective collaborate to create novel insect-resistant crops 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3Sanitized Medical Joysticks for a Safer and Healthier Work Environment 2
... July 17 Encorium Group, Inc. (Nasdaq: ... research organization (CRO) that provides design, development, and management ... of the world,s leading pharmaceutical companies, today announced that ... Company,s U.S. business to Pierrel Research USA, Inc., a ...
... 16 Nile Therapeutics, Inc. (Nasdaq: NLTX ), a ... patients, today announced that it has completed a private placement of ... stock for aggregate gross proceeds of approximately $3.4 million. Riverbank Capital ... agent for the transaction. , , ...
... - Introductory Webinar, July 21st, 11am EDT, ... September 15-16, San Diego,CA , ChemAxon, a ... Excel. The add-in for Microsoft Excel(R),brings all of the capabilities and ... will be introduced at a free webinar,on July 21st and Workshop ...
Cached Biology Technology:Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 2Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 3Encorium Group Completes Sale of its U.S. Business to Pierrel Research USA; Announces Management Changes 4Nile Therapeutics, Inc. Completes $3.4 Million Private Placement 2Nile Therapeutics, Inc. Completes $3.4 Million Private Placement 3ChemAxon Launches JChem for Excel 2
(Date:6/30/2015)... June 30, 2015 Genisphere announced ... CEO to help further develop Genisphere,s therapeutics capabilities and ... experience, having spent much of the last 25 years ... Baxter Bioscience, and Johnson & Johnson. Tom started his ... and Biotech Corporate Finance. He graduated from Dartmouth College ...
(Date:6/26/2015)... Utah , June 26, 2015 ATL Technology, ... and devices with specialties in single use solutions, headquartered in ... of MedConx, Inc. (a California corporation ... and San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility ...
(Date:6/25/2015)...  Imagine a tool specifically designed to help you ... That,s exactly what USANA,s True Health Assessment ... health program provides a personalized approached to measuring your ... lifestyle and nutrition. At the Canadian ... USANA,s THA was honored with the Industry Innovation Award. ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... Ecosystem ecologist Ann Bartuska will give a free public lecture ... managers are doing to respond to climate change and to ... lecture, titled "Climate Change, Bark Beetles, Environmental Markets and Sustainability: ... place at 4:10 p.m., April 5, in Bourns Hall ...
... that prenatal health care professionals are concerned about patients, ... effective counseling. Rates of excessive weight gain during ... health outcomes for mothers and children, have increased in ... providers agree that weight gain is an important topic ...
... Iowa USA - A leading scientific journal in Pakistan, ... ,* recently published a paper titled "A New ... Ancient Approach to Peace," indicating that the military application ... discusses how militaries worldwide could use the Transcendental Meditation ...
Cached Biology News:UC Riverside lecture: Climate change, bark beetles, environmental markets and sustainability 2Prenatal health-care providers inconsistent in weight-gain counseling 2Military application of Transcendental Meditation gaining acceptance 2Military application of Transcendental Meditation gaining acceptance 3Military application of Transcendental Meditation gaining acceptance 4
... 1 kit. Facilitates the simple, phenol-free extraction ... hard tissue requiring proteinase K digestion.Each kit ... from 50 preparations of up to 25 ... & Purification, Purification and Amplification of Genomic ...
Request Info...
Ultra-sensitive, non-radioactive measurement of COX-I and COX-II activity...
Recombinant Ovine (Sheep) Growth Hormone, Ultra Pure...
Biology Products: